Simona Carnio
Overview
Explore the profile of Simona Carnio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Celio L, Cortinovis D, Cogoni A, Cavanna L, Martelli O, Carnio S, et al.
Oncologist
. 2021 Jun;
26(10):e1854-e1861.
PMID: 34101934
Background: To reduce the overall exposure to dexamethasone (DEX) in patients receiving cisplatin-based chemotherapy, we evaluated the noninferiority of DEX on day 1, with or without low-dose DEX on days...
12.
Mezquita L, Preeshagul I, Auclin E, Saravia D, Hendriks L, Rizvi H, et al.
Eur J Cancer
. 2021 May;
151:211-220.
PMID: 34022698
Background: dNLR at the baseline (B), defined by neutrophils/[leucocytes-neutrophils], correlates with immune-checkpoint inhibitor (ICI) outcomes in advanced non-small-cell lung cancer (aNSCLC). However, dNLR is dynamic under therapy and its longitudinal...
13.
Cecchi C, Mariniello A, Carnio S, Delcuratolo M, Novello S
Clin Lung Cancer
. 2021 Apr;
22(6):e804-e807.
PMID: 33903029
No abstract available.
14.
Jacobs F, Carnio S, DE Stefanis P, Luciano A, Novello S
Eur J Cancer
. 2021 Apr;
149:114-116.
PMID: 33857885
No abstract available.
15.
Bertaglia V, Reale M, Bironzo P, Palesandro E, Mariniello A, Leone G, et al.
Crit Rev Oncol Hematol
. 2020 Dec;
157:103189.
PMID: 33341505
This study investigated the clinical management of non small cell lung cancer (NSCLC) patients during the first wave of coronavirus disease 2019 (COVID-19) outbreak in Italy. A 29-questions survey was...
16.
Bersanelli M, Giannarelli D, De Giorgi U, Pignata S, Di Maio M, Verzoni E, et al.
Ther Adv Med Oncol
. 2020 Nov;
12:1758835920968463.
PMID: 33224275
Background: This prospective, multicentre, observational INVIDIa-2 study is investigating the clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune-checkpoint inhibitors (ICIs), enrolled in 82 Italian centres, from October 2019...
17.
Cortellini A, Tiseo M, Banna G, Cappuzzo F, Aerts J, Barbieri F, et al.
Cancer Immunol Immunother
. 2020 Jun;
69(11):2209-2221.
PMID: 32474768
Background: Single-agent pembrolizumab represents the standard first-line option for metastatic non-small-cell lung cancer (NSCLC) patients with a PD-L1 (programmed death-ligand 1) expression of ≥ 50%. Methods: We conducted a multicenter...
18.
Tabbo F, DAveni A, Tota D, Pignataro D, Bironzo P, Carnio S, et al.
J Thorac Oncol
. 2019 Jan;
14(2):e38-e40.
PMID: 30683298
No abstract available.
19.
Carnio S, Di Stefano R, Novello S
Lung Cancer (Auckl)
. 2017 Feb;
7:73-82.
PMID: 28210163
Lung cancer (LC) remains the most common cause of cancer death in several countries across the world. Fatigue is the most frequently reported symptom in LC patients throughout the entire...
20.
Pacchiana M, Capelletto E, Carnio S, Gridelli C, Rossi A, Galetta D, et al.
Clin Lung Cancer
. 2016 Dec;
18(4):381-387.
PMID: 27965013
Introduction: Pemetrexed maintenance therapy (MT) after induction with platinum-based chemotherapy has recently become a common treatment strategy for advanced nonsquamous non-small-cell lung cancer (NSCLC). However, the benefits of MT should...